HCA Holdings Inc (HCA)

HCA (NYSE:Health Services)
neg -0.27
Today's Range: 68.94 - 69.46 | HCA Avg Daily Volume: 3,322,200
Last Update: 08/28/14 - 4:01 PM EDT
Volume: 1,153,083
YTD Performance: 45.15%
Open: $69.25
Previous Close: $69.25
52 Week Range: $37.99 - $69.72
Oustanding Shares: 432,385,100
Market Cap: 29,951,315,877
6-Month Chart
TheStreet Ratings Grade for HCA
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 13 13 13 13
Moderate Buy 2 2 2 2
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.22 1.22 1.22 1.22
Latest Dividend: 2.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/13/12
Price Earnings Ratio: 18.57
Price Earnings Comparisons:
HCA Sector Avg. S&P 500
18.57 19.60 28.96
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
30.37% 79.87% 255.13%
Revenue 3.50 0.11 0.04
Net Income -0.50 0.27 0.08
EPS -3.60 0.24 0.07
Earnings for HCA:
Revenue 34.18B
Average Earnings Estimates
Qtr (09/14) Qtr (12/14) FY (12/14) FY (12/15)
Average Estimate $0.96 $1.10 $4.21 $4.73
Number of Analysts 13 12 11 14
High Estimate $1.08 $1.33 $4.38 $5.26
Low Estimate $0.91 $1.04 $4.00 $4.34
Prior Year $0.79 $0.92 $3.41 $4.21
Growth Rate (Year over Year) 20.93% 19.93% 23.57% 12.17%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands

This Morning's Market Setup Real Money Pro($)

Where it began.
Unintended consequences of the law could benefit these operators.
In the short term, insurers and providers should continue to benefit from Obamacare.
Dec 18, 2013 | 7:50 AM EST
HCA was placed on the Conviction Buy list, according to Goldman Sachs. Company trades at a compelling valuation and has multiple potent...
Nov 06, 2013 | 8:27 AM EST
HCA estimates were raised through 2015, Bank of America/Merrill Lynch said. Company is seeing higher sales and margins. Buy rating and ...
Neither side is voting their interests.
Sep 18, 2013 | 7:01 AM EDT
HCA was upgraded from Neutral to Buy, Mizuho said. $51 price target. Company should benefit from healthcare reform.   
These stocks all pique my interest at current levels.
This sector is outperforming, and these two names are compelling on a pullback.
Dec 18, 2012 | 7:38 AM EST
HCA was initiated with an Overweight rating, JP Morgan said. $39 price target. Company is leveraged to industry reform. 

Columnist Conversations

If this market has taught us one thing over the past 5 years, it has been to not be dogmatic in our views. Th...
Is this the biotech revolution or the biotech bust? View Small Cap Biotechs Like Never Before: Transparency is...
Market recovers a bit from early losses after European Bourses close at 11:30am EST. Upwardly revised Q2 GDP ...
When I do an article on a stock I do my best to define the risk on the trade. Sometimes I get to follow up an...


Columnist Tweets


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.